X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4123) 4123
Publication (589) 589
Newspaper Article (320) 320
Newsletter (267) 267
Book Review (56) 56
Book Chapter (42) 42
Book / eBook (25) 25
Conference Proceeding (19) 19
Trade Publication Article (10) 10
Dissertation (6) 6
Magazine Article (4) 4
Data Set (1) 1
Reference (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2442) 2442
tumors (2355) 2355
cancer (2180) 2180
oncology (1724) 1724
humans (1560) 1560
tumor microenvironment (1534) 1534
immunotherapy (1404) 1404
metastasis (1023) 1023
animals (1002) 1002
immunology (795) 795
research (781) 781
lymphocytes (637) 637
expression (596) 596
development and progression (552) 552
cancer therapies (547) 547
chemotherapy (540) 540
care and treatment (537) 537
t cells (530) 530
review (523) 523
cell biology (520) 520
female (499) 499
metastases (499) 499
mice (484) 484
article (478) 478
breast cancer (477) 477
analysis (462) 462
gene expression (454) 454
apoptosis (437) 437
macrophages (434) 434
melanoma (434) 434
dendritic cells (433) 433
lymphocytes t (426) 426
antigens (425) 425
health aspects (423) 423
immune system (421) 421
cell line, tumor (419) 419
angiogenesis (412) 412
cytokines (404) 404
proteins (404) 404
inflammation (397) 397
stem cells (382) 382
medical research (380) 380
fibroblasts (378) 378
breast-cancer (370) 370
medical prognosis (355) 355
neoplasms. tumors. oncology. including cancer and carcinogens (353) 353
therapy (350) 350
biochemistry & molecular biology (344) 344
cells (321) 321
signal transduction (315) 315
hypoxia (313) 313
patients (311) 311
prognosis (307) 307
microenvironment (302) 302
immune response (299) 299
neoplasms - immunology (298) 298
tumor (298) 298
cytotoxicity (295) 295
t-cells (290) 290
neoplasms - pathology (287) 287
biomarkers (283) 283
medicine (281) 281
clinical trials (279) 279
kinases (279) 279
genetic aspects (273) 273
colorectal cancer (271) 271
male (268) 268
activation (267) 267
growth (266) 266
tumor-associated macrophages (265) 265
immune checkpoint (264) 264
survival (264) 264
regulatory t-cells (262) 262
medicine, research & experimental (256) 256
tumor cells (256) 256
nanoparticles (251) 251
lung cancer (248) 248
neoplasms - therapy (248) 248
tumor microenvironment - immunology (247) 247
cell proliferation (242) 242
suppressor-cells (241) 241
pharmacology & pharmacy (240) 240
progression (238) 238
multidisciplinary sciences (237) 237
epithelial-mesenchymal transition (233) 233
pancreatic cancer (233) 233
biology (221) 221
in-vivo (219) 219
immunity (218) 218
drug therapy (208) 208
immunosuppression (208) 208
physiological aspects (208) 208
extracellular matrix (207) 207
metabolism (207) 207
chemistry, multidisciplinary (203) 203
carcinoma (202) 202
stromal cells (201) 201
mutation (199) 199
ligands (195) 195
solid tumors (188) 188
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (10) 10
Scarborough Hospital - Birchmount (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Credit Valley Hospital - Stacks (1) 1
Humber River Regional Hospital - Finch Stacks (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Providence Healthcare - Stacks (1) 1
Scarborough Hospital - General (1) 1
St Josephs Health Centre - Stacks (1) 1
St. Michael's Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4758) 4758
Chinese (9) 9
Japanese (4) 4
Hebrew (2) 2
Korean (2) 2
French (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Immunology Research, ISSN 2314-8861, 2019, Volume 2019, pp. 3046379 - 12
Cellular components of the tumour microenvironment (TME) are recognized to regulate the hallmarks of cancers including tumour proliferation, angiogenesis,... 
CD8(+) T-CELLS | IMMUNOLOGY | Developed countries | Medical research | Lung cancer | MiRNA | Non-small cell lung carcinoma | Breast cancer | Biosynthesis | Pharmacology | Metastasis | Males | Chemical compounds | Metastases | Anticancer properties | Proteins | Angiogenesis | Lungs | Stromal cells | MicroRNAs | Fibroblasts | Regulation | Females | Cytoplasm | Cancer | Tumors
Journal Article
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, ISSN 1422-0067, 09/2019, Volume 20, Issue 17, p. 4320
The tumor microenvironment (TME) is a complex entity where host immune and non-immune cells establish a dynamic crosstalk with cancer cells. Through cell-cell... 
pre-metastatic niche (PMN) | tumor microenvironment (TME) | PD-1 BLOCKADE | BIOCHEMISTRY & MOLECULAR BIOLOGY | TRAFFICKING | immune cells | RECEPTOR | ANTITUMOR-ACTIVITY | CANCER | CHEMISTRY, MULTIDISCIPLINARY | CD8(+) T-CELLS | DENDRITIC CELL-FUNCTION | tumor invasion | immunotherapy | EXPRESSION | PLUS IPILIMUMAB
Journal Article
Life Sciences, ISSN 0024-3205, 11/2019, p. 117049
Journal Article
by Bai, S and Ma, XQ and Shi, XX and Shao, JJ and Zhang, T and Wang, YJ and Cheng, YL and Xue, P and Kang, YJ and Xu, ZG
ACS APPLIED MATERIALS & INTERFACES, ISSN 1944-8244, 10/2019, Volume 11, Issue 39, pp. 36130 - 36140
Low delivery efficiency and limited tumor penetration of nanoparticle-based drug delivery systems (DDSs), the two most concerned issues in tumor therapy, have... 
CANCER-CELLS | tumor microenvironment (TME) | DRUG-DELIVERY | MATERIALS SCIENCE, MULTIDISCIPLINARY | NANOSCIENCE & NANOTECHNOLOGY | tumor penetration | HYPOXIA | dual-redox response | cancer therapy | PRODRUG | NANOPARTICLE SIZE | ROS | SYSTEMS | delivery efficiency | ACCUMULATION
Journal Article
Human Pathology, ISSN 0046-8177, 05/2018, Volume 75, pp. 81 - 90
Programmed cell death protein 1 (PD-1) and indoleamine 2,3-dioxygenase (IDO) are both immunosuppressive proteins. Here, we investigated the relationship... 
Tumor microenvironment (TME) | Breast cancer | Tumor-draining lymph nodes (TDLNs) | IDO | PD-1 | TCGA dataset | PATHWAYS | IMMUNITY | PATHOLOGY | THERAPY | IMMUNOTHERAPY | POOR-PROGNOSIS | CARCINOMA | LYMPHOCYTES | Proteins | Immunohistochemistry | Antigens | Metastasis | Apoptosis
Journal Article
Journal of Cellular Physiology, ISSN 0021-9541, 09/2019, Volume 234, Issue 9, pp. 14622 - 14632
Tumor cell invasion and metastasis are the definitive cause of mortality in breast cancer (BC). Hypoxia and pro‐inflammatory cytokines upregulate the CD73 gene... 
breast cancer | CD73 | tumor microenvironment (TME) | ectonucleotidase | Development and progression | Breast cancer | Pathways | Cytokines | Mortality | Breast | Hypoxia | CD73 antigen | Ectonucleotidase | Inflammation | Tumors | Metastases
Journal Article
Frontiers in Oncology, ISSN 2234-943X, 11/2019, Volume 9
Tumor cells must generate sufficient ATP and biosynthetic precursors in order to maintain cell proliferation requirements. Otto Warburg showed that tumor cells... 
Health aspects | Tumors | Cell proliferation | Care and treatment | Glycolysis | Genetic aspects | Research | Oxidoreductases | Cancer | tumor microenvironment (TME) | acidification | lactate | immune response | therapy
Journal Article
Life Sciences, ISSN 0024-3205, 12/2019, Volume 238, p. 116960
Cancer is a disease of high complexity. Resistance to therapy is a major challenge in cancer targeted therapies. Overcoming this resistance requires a deep... 
Tumor microenvironment (TME) | Melatonin | Mitochondria | Cytotoxic T lymphocytes (CTLs) | Natural killer (NK) cells | T regulatory cells (tregs) | Cancer | Immune system
Journal Article
Methods in Enzymology, ISSN 0076-6879, 2019
Homing of tumor-specific cytotoxic T lymphocytes (CTLs) to the tumor tissues represents a vital step in procuring an effective anti-tumor immune response.... 
Dendritic cell (DC) | Tumor microenvironment (TME) | Cytotoxic T lymphocyte (CTL) | Murine models | Immunotherapy | Immune checkpoint inhibitor (ICI) | Oncology | Tumor-associated lymphocyte (TAL) | Tumor-infiltrating lymphocyte (TIL) | ELISpot | Cancer
Journal Article
ONCOTARGET, ISSN 1949-2553, 01/2017, Volume 8, Issue 5, pp. 8633 - 8647